DiaMedica Therapeutics Inc. (DMAC) Reports Q3 Loss of $0.20/Share

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) reported Q3 EPS of ($0.20), versus ($0.18) reported last year.

For earnings history and earnings-related data on DiaMedica Therapeutics Inc. (DMAC) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance
• Humanoid robot component stocks surge on supply-chain optimism